Frontiers in Psychiatry (Feb 2022)

Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders

  • Anthony L. Vaccarino,
  • Derek Beaton,
  • Derek Beaton,
  • Sandra E. Black,
  • Sandra E. Black,
  • Pierre Blier,
  • Farnak Farzan,
  • Elizabeth Finger,
  • Jane A. Foster,
  • Morris Freedman,
  • Benicio N. Frey,
  • Benicio N. Frey,
  • Susan Gilbert Evans,
  • Keith Ho,
  • Mojib Javadi,
  • Sidney H. Kennedy,
  • Raymond W. Lam,
  • Anthony E. Lang,
  • Anthony E. Lang,
  • Bianca Lasalandra,
  • Sara Latour,
  • Mario Masellis,
  • Roumen V. Milev,
  • Daniel J. Müller,
  • Daniel J. Müller,
  • Douglas P. Munoz,
  • Sagar V. Parikh,
  • Franca Placenza,
  • Susan Rotzinger,
  • Susan Rotzinger,
  • Claudio N. Soares,
  • Alana Sparks,
  • Stephen C. Strother,
  • Stephen C. Strother,
  • Richard H. Swartz,
  • Richard H. Swartz,
  • Brian Tan,
  • Maria Carmela Tartaglia,
  • Valerie H. Taylor,
  • Elizabeth Theriault,
  • Gustavo Turecki,
  • Rudolf Uher,
  • Lorne Zinman,
  • Kenneth R. Evans

DOI
https://doi.org/10.3389/fpsyt.2022.816465
Journal volume & issue
Vol. 13

Abstract

Read online

The Ontario Brain Institute's “Brain-CODE” is a large-scale informatics platform designed to support the collection, storage and integration of diverse types of data across several brain disorders as a means to understand underlying causes of brain dysfunction and developing novel approaches to treatment. By providing access to aggregated datasets on participants with and without different brain disorders, Brain-CODE will facilitate analyses both within and across diseases and cover multiple brain disorders and a wide array of data, including clinical, neuroimaging, and molecular. To help achieve these goals, consensus methodology was used to identify a set of core demographic and clinical variables that should be routinely collected across all participating programs. Establishment of Common Data Elements within Brain-CODE is critical to enable a high degree of consistency in data collection across studies and thus optimize the ability of investigators to analyze pooled participant-level data within and across brain disorders. Results are also presented using selected common data elements pooled across three studies to better understand psychiatric comorbidity in neurological disease (Alzheimer's disease/amnesic mild cognitive impairment, amyotrophic lateral sclerosis, cerebrovascular disease, frontotemporal dementia, and Parkinson's disease).

Keywords